Different Medications to Induce Labor

Recruiting Phase 3 Interventional Study
Pregnancy Labor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
281 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30 Exclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30
Contacts

Nicola F Tavella, MPH

2122413888

nicola.tavella@mssm.edu

CONTACT

Allison Perelman, MD

allison.perelman@mssm.edu

CONTACT